The efficacy of auranofin regardless of p53 functionality was also observed in p53 mutant refractory B-cell lymphoma, which happens to also carry a deletion in the tumor suppressor PTEN [72]. Here, TP53 is linked to B-cell non-Hodgkin lymphoma.